Key result
Serum lncRNA DBH-AS1 was down-regulated in T2DM patients with CHD and predicted cardiovascular events, which included acute myocardial infarction (23.75%) and severe arrhythmia (22.50%).
Why the study?
Coronary heart disease is a prevalent complication in type 2 diabetes mellitus, prompting investigation into the levels and predictive role of DBH-AS1 for significant cardiovascular events.
Does the level of lncRNA DBH-AS1 predict the occurrence of cardiovascular events in patients with type 2 diabetes mellitus and coronary heart disease?
Observational
Does the level of lncRNA DBH-AS1 predict the occurrence of cardiovascular events in patients with type 2 diabetes mellitus and coronary heart disease?
Answers are grounded in this paper and cite their sources.
Down-regulation of serum lncRNA DBH-AS1 may serve as a novel biomarker for predicting major adverse cardiovascular events in patients with concurrent type 2 diabetes and coronary heart disease.
BACKGROUND: The frequency of type 2 diabetes mellitus (T2DM) is rising annually. Coronary heart disease (CHD) is a prevalent complication affecting individuals with T2DM. OBJECTIVE: The aim of this investigation was to assess the level of DBH-AS1 in T2DM with CHD, and to determine its potential role in forecasting the occurrence of significant cardiovascular events. METHODS: The DBH-AS1 levels were detected by qRT-PCR. The diagnostic value of DBH-AS1 was assessed through receiver operating characteristic (ROC) curve analysis. Logistic regression was conducted to identify the risk factors for cardiovascular events among patients with T2DM with CHD. Cell proliferation was detected by Cell Counting Kit-8 (CCK-8) assay, apoptosis was detected by flow cytometry, and the concentration of inflammatory factors was detected by Enzyme Linked Immunosorbent (ELISA) kit. RESULTS: DBH-AS1 was down-regulated in serum of both T2DM with CHD and cardiovascular events patients. Of the cardiovascular events that occurred, major events included recurrent angina (20%), cardiovascular death (7.5%), acute myocardial infarction (23.75%), severe arrhythmia (22.50%), acute heart failure (18.75%) and stroke (7.5%). And DBH-AS1 had a predictive value for each adverse of cardiovascular events. DBH-AS1 regulated the expression of miR-483-5p and affected the proliferation, apoptosis, and secretion of inflammatory factors of HCAECs. CONCLUSION: DBH-AS1 may serve as a predictor for the occurrence of cardiovascular events in T2DM with CHD patients.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) conducted an observational in Type 2 diabetes mellitus with coronary heart disease. lncRNA DBH-AS1 was evaluated on Cardiovascular events. Serum lncRNA DBH-AS1 was down-regulated in T2DM patients with CHD and predicted cardiovascular events, which included acute myocardial infarction (23.75%) and severe arrhythmia (22.50%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: